( 06821.hk)
市盈率21.38市净率1.06市销率3.08股息率3.68%上市时间2021-12-10股价53.20港币 (-3.62% , 749.91万港币) 市值195.63亿港币总股本3.68亿上市至今年化投资收益率-40.78%港股通持仓占H股比例49.23%累计做空占H股本比3.65%
所属三级行业药品 (恒生) 市盈率17.01市净率1.41市销率1.10股息率3.12%
所属指数指数纳入纳出
同股同权查看历史折扣
备注 (2): 双击编辑备注
发表讨论

凯莱英(06821) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孫雪嬌Independent Non Executive Director - A/F2023-10-18--
2李家聰Independent Non Executive Director2021-06-16--
3張婷Non Executive Director2021-02-09--
4王青松Independent Non Executive Director2019-04-18--
5張達Executive Director2018-08-07--
6張昆Independent Non Executive Director - A/F2017-01-162023-10-18
7HONG HaoExecutive DirectorChairman, CEO2011-07-18--
8洪亮Executive Director2011-07-18--
9SONG YeNon Executive Director2011-07-18--
10楊蕊Executive Director2011-07-18--